Iteos Therapeutics Stock Investor Sentiment
| ITOS Stock | USD 6.96 0.13 1.83% |
Slightly above 86 percent of Iteos Therapeutics' private investors are aggressively looking to sell. The analysis of the overall investor sentiment regarding Iteos Therapeutics suggests that a very large number of traders are panicking. Iteos Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Iteos Therapeutics' earnings reports, geopolitical events, and overall market trends.
Iteos |
Iteos Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Iteos Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Iteos Therapeutics that are available to investors today. That information is available publicly through Iteos media outlets and privately through word of mouth or via Iteos internal channels. However, regardless of the origin, that massive amount of Iteos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Iteos Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Iteos Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Iteos Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Iteos Therapeutics alpha.
Iteos Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | On The My Stocks Page - Stock Traders Daily | 01/15/2025 |
2 | Acquisition by Feltquate David of 47000 shares of Iteos Therapeutics subject to Rule 16b-3 | 01/31/2025 |
3 | iTeos Therapeutics, Inc. Sees Significant Decline in Short Interest - MarketBeat | 02/03/2025 |
4 | Acquisition by Davis Aaron I. of 24200 shares of Iteos Therapeutics at 16.32 subject to Rule 16b-3 | 02/07/2025 |
5 | ITOS stock touches 52-week low at 7.09 amid market challenges - Investing.com | 02/11/2025 |
6 | ITOS stock touches 52-week low at 7.09 amid market challenges - MSN | 02/27/2025 |
7 | iTeos Therapeutics GAAP EPS of -1.01 beats by 0.05 | 03/05/2025 |
8 | iTeos Therapeutics Full Year 2024 Earnings In Line With Expectations | 03/06/2025 |
9 | iTeos gibt Geschftsergebnisse fr das vierte Quartal und das Gesamtjahr 2024 sowie Unternehmensneuigkeiten bekannt | 03/07/2025 |
10 | Wall Street Analysts Think iTeos Therapeutics Could Surge 212.5 percent Read This Before Placing a Bet | 03/13/2025 |
11 | Disposition of 115000 shares by Davis Aaron I. of Iteos Therapeutics at 27.0145 subject to Rule 16b-3 | 03/14/2025 |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.